benzoquinoxaline has been researched along with quinoxalines in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Klein, O; Porra, RJ | 1 |
Bisagni, E; Escudé, C; Garestier, T; Hélène, C; Janin, Y; Kukreti, S; Nguyen, CH; Sun, JS | 1 |
Bergquist, H; Fernández, RD; Good, L; Larsson, V; Nguyen, CH; Nikravesh, A; Zain, R | 1 |
Buroni, S; de Jesus Lopes Ribeiro, AL; Degiacomi, G; Molteni, E; Pasca, MR; Riccardi, G | 1 |
Hu, MH; Lin, JH | 1 |
1 review(s) available for benzoquinoxaline and quinoxalines
Article | Year |
---|---|
Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
Topics: Antitubercular Agents; Arabinose; Enzyme Inhibitors; Mycobacterium bovis; Mycobacterium tuberculosis; Oxidoreductases; Quinoxalines; Racemases and Epimerases | 2012 |
4 other study(ies) available for benzoquinoxaline and quinoxalines
Article | Year |
---|---|
The determination of 4,5-dioxovaleric acid in plant preparations and a procedure for the assay of L-alanine:4,5-dioxovaleric acid aminotransferase (EC 2.6.1.43) activity.
Topics: 2-Naphthylamine; Aminolevulinic Acid; Hydrogen-Ion Concentration; Keto Acids; Methods; Plants; Pyruvates; Pyruvic Acid; Quinoxalines; Rhodobacter sphaeroides; Spectrophotometry, Ultraviolet; Transaminases; Valerates | 1981 |
Rational design of a triple helix-specific intercalating ligand.
Topics: Animals; DNA; Gene Expression Regulation; Humans; Ligands; Models, Molecular; Nucleic Acid Conformation; Quinoxalines | 1998 |
Structure-specific recognition of Friedreich's ataxia (GAA)n repeats by benzoquinoquinoxaline derivatives.
Topics: DNA; Friedreich Ataxia; Humans; Nucleic Acid Conformation; Plasmids; Quinoxalines | 2009 |
New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; DNA Damage; DNA Topoisomerases, Type I; Down-Regulation; Drug Design; Female; G-Quadruplexes; Humans; Ligands; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-myc; Quinoxalines; Transplantation, Heterologous; Triple Negative Breast Neoplasms | 2021 |